FUNCTIONAL AREAS – Page 6

Rework decision conflict on the shop floor – CAPA plan that survives FDA/EMA questions

Identifying symptoms of rework decision conflicts early can significantly mitigate risks associated with product quality and compliance. Some common signals that may indicate a pending conflict include:Click to read the…

Line clearance lapse during campaign changeover – inspection-ready evidence pack checklist

Identifying the symptoms and signals of a line clearance lapse is the first step in managing the risk associated with campaign changeover in pharmaceutical manufacturing. Observations may include:Click to read…

Rework decision conflict during tech transfer execution – CAPA plan that survives FDA/EMA questions

The first step in addressing rework decision conflicts is recognizing the symptoms that indicate a problem. These signals can manifest at various stages of tech transfer:Click to read the full…

Batch record discrepancy during scale-up – CAPA plan that survives FDA/EMA questions

Identifying symptoms or signals of a batch record discrepancy is essential to initiate an investigation. These symptoms can surface in various forms, including:Click to read the full article.

Unplanned process deviation during tech transfer execution – who owns the investigation and how to document it

Recognizing the symptoms or signals of an unplanned process deviation is the first critical step toward remediation. Symptoms may manifest in various forms, including:Click to read the full article.

Rework decision conflict during campaign changeover – batch disposition decision tree for QA alignment

Recognizing the symptoms of rework decision conflicts during campaign changeovers is crucial for timely intervention. Symptoms may manifest as:Click to read the full article.

Critical IPC step missed during batch review closeout – CAPA plan that survives FDA/EMA questions

The first step in addressing a missed IPC step is recognizing the symptoms or signals that indicate potential issues during the batch review process. These signals may manifest in various…

Rework decision conflict during tech transfer execution – batch disposition decision tree for QA alignment

Identifying signals that indicate a potential rework decision conflict is crucial for timely intervention. Common symptoms may include:Click to read the full article.

Batch record discrepancy during batch review closeout – CAPA plan that survives FDA/EMA questions

Recognizing the symptoms of batch record discrepancies early is crucial for minimizing risks and mitigating potential issues. Symptoms may include:Click to read the full article.

Critical IPC step missed during unplanned downtime – batch disposition decision tree for QA alignment

The initial phase of an investigation revolves around identifying symptoms or signals that indicate a deviation has occurred. In the case of missed critical IPC steps during unplanned downtime, symptoms…

Unplanned process deviation on the shop floor – inspection-ready evidence pack checklist

Detection of unplanned process deviations often begins with the observation of symptoms or signals either on the manufacturing floor or within the lab environment. Recognizing these signals early is crucial…

Rework decision conflict during scale-up – CAPA plan that survives FDA/EMA questions

The first step in any investigation is recognizing signals of a potential issue. Symptoms that indicate a conflict in the rework process can manifest in various ways, including:Click to read…